-
Fury claims Joshua bout is off, calls for Usyk trilogy
-
Dukascopy Bank Unveils AI-Powered Trading, 25,000+ Stock CFDs and a New Flagship E-Banking App
-
British family bids to row back against suicide taboo
-
Tech firms rally but Asian markets mixed, with eyes on US inflation
-
China's teenage 223cm basketball player 'just a little girl'
-
Nepal holds day of mourning as families pray missing still alive
-
Tokyo's Shinjuku to ban more than half of vacation rentals
-
African players in Europe: Mbeumo fires solo goal as United draw
-
Australian Rules limits contact training to reduce concussion
-
Malaysia cancels haze emergency, but warns problems remain
-
Germany's Merz under pressure from far-right election triumph
-
Philippine sensation Eala looks forward to Asian Games 'fun'
-
Nepal tunnel rescues face 'unprecedented' challenge
-
Jakarta airport extends closure after volcano eruption
-
Mourinho's Real Madrid European revival bid starts with Inter reunion
-
Lonely woman director in Venice sees industry backsliding on gender
-
Solomons PM survives attempt to oust government
-
Tech firms rally on mixed day for Asian markets, with eyes on US inflation
-
Ohtani 'unlikely' to pitch again this season, says Dodgers manager
-
World number one An sends Asian Games warning with China hat-trick
-
Driver thanks 'superhero' rival for saving him from flaming race car
-
PSG go for three in a row as Champions League returns
-
Can dogs sniff cancer? AI joins the hunt in India
-
"Super-human' Alcaraz books US Open quarter-final clash with Shelton
-
Shelton steams into US Open quarter-final clash with Alcaraz
-
ECB set to hike interest rates as Iran war flares anew
-
25 years on, America seeks to keep 9/11 memories alive
-
AI data centers are less thirsty now, tech giants say
-
'Trumpapalooza' tests Republican bet on unpopular US president
-
North Korea vows nuclear-armed navy as US ally drills open
-
Pegula tops Cirstea to reach US Open quarter-finals
-
Under-fire Labuschagne named in Australia Test squad for South Africa
-
Australians could opt out of social media algorithms under new law
-
Best Way to Protect A 401(k) in 2026: Guide Released by Experts
-
Genflow Biosciences PLC Announces Appointment of Investor Relations Adviser
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 07
-
Enjoying the moment: Alcaraz steps it up to reach US Open quarter-finals
-
Tiafoe tops Medvedev in straight sets at US Open
-
Five dead, five injured after Amazon cargo plane overshoots Miami runway
-
Zverev seeks US Open last eight as Osaka faces Rybakina
-
La Rochelle half-backs lead fightback against Toulouse
-
Alcaraz turns up heat to reach US Open quarters
-
US envoys have 'more effective proposals': Ukraine official
-
Gatti salvages Juve draw with AC Milan in Serie A
-
Defending champion Alcaraz powers into US Open quarter-finals
-
Sinayoko stars as unbeaten Paris FC down Marseille
-
Amazon cargo plane overshoots Miami runway, hits vehicles, catches fire
-
Still on top: 'Spider-Man' dominates North American box office
-
Toll from Yemen clashes passes 300 as civilians flee homes
-
Zelensky in fresh talks with US envoys: Ukraine official
KindlyMD Approved for Options Trading on Nasdaq
SALT LAKE CITY, UT / ACCESS Newswire / September 10, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury vehicle via its subsidiary Nakamoto Holdings ("Nakamoto"), today announced that options on its common stock have been approved for trading tomorrow on the Nasdaq Options Market ("Nasdaq").
Trading of KindlyMD options will commence under the ticker symbol "NAKA" and includes a range of standard expiration dates and strike prices. The introduction of listed options is expected to broaden investor visibility and provide shareholders with additional tools to manage risk, leverage positions, and engage with KindlyMD's long-term growth strategy.
"The commencement of options trading on the Nasdaq marks another important milestone for KindlyMD, further enhancing our capital markets presence and providing shareholders with greater flexibility in how they invest in the Nakamoto story," said David Bailey, Chairman and CEO of KindlyMD.
Institutional and retail investors can access NAKA options through major brokerage platforms and trading networks that support equity options on the Nasdaq exchange.
About KindlyMD
KindlyMD® is a patient-first and healthcare data company redefining value-based care and patient-centered medical services. Formed in 2019, KindlyMD leverages data analysis to deliver evidence-based, personalized solutions in order to reduce opioid use, improve health outcomes faster, and provide value based, algorithmic guidance on the use of alternative medicine in healthcare. In August 2025, KindlyMD completed its merger with Nakamoto Holdings Inc., a Bitcoin-native holding company. This strategic partnership formed a public Bitcoin treasury strategy that unites KindlyMD's healthcare expertise with Nakamoto's vision of integrating Bitcoin into global capital markets, creating a diversified entity focused on both healthcare innovation and Bitcoin treasury management.
Forward-Looking Statements
All statements, other than statements of historical fact, included in this press release that address activities, events or developments that that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements, as defined under U.S. federal securities laws, related to the Company. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and often include statements about our future operations, business strategies, plans, objectives, expectations, intentions, goals, projections, prospects, future events, or performance, as well as underlying assumptions. These statements-covering matters such as expectations, plans, strategic outlooks, financial projections, market conditions, regulatory environments, Bitcoin-related strategies, Bitcoin treasury management activities, and the Company's anticipated holding of Bitcoin as part of its corporate treasury are inherently uncertain and involve numerous assumptions and risks.
Forward-looking terms used may include, but are not limited to, "estimate," "project," "predict," "believe," "expect," "anticipate," "potential," "create," "intend," "could," "would," "may," "plan," "will," "guidance," "look," "goal," "future," "build," "focus," "continue," "strive," "allow," "seek," "aim," "target," or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements and similar expressions. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, descriptions of the Company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, including the purchase, custody, and potential sale or other use of Bitcoin, synergies, opportunities and anticipated future performance, including the management team and board of directors of the Company. These statements may also relate to broader macroeconomic trends, industry developments, technology adoption, competitive positioning, market expansion, product launches, research and development efforts, acquisitions or dispositions, legal or regulatory developments, and other initiatives that could affect our future business performance. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this communication. These include risks relating to Bitcoin market volatility, cybersecurity and custody of digital assets, potential changes in laws or accounting standards relating to cryptocurrency, and regulatory developments affecting Bitcoin or other digital assets, as well as the risk that changes in the Company's capital structure and governance could have adverse effects on the market value of its securities; the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on the Company operating results and business generally; the risk that the Company may be unable to reduce expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations or enforcement practices; adverse impacts from geopolitical events, health crises, supply chain disruptions, changes to laws or accounting standards, cybersecurity threats or data breaches, intellectual property disputes, competitive pressures, or changes in consumer behavior; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond the Company's control, including those detailed in the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10- Q, Current Reports on Form 8-K, and such other documents of the Company filed, or to be filed, with the SEC that are or will be available on the Company's website at www.kindlymd.com and on the website of the SEC at www.sec.gov. All forward-looking statements are based on assumptions that the Company believes to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not undertake any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Nothing contained herein constitutes an offer to buy or sell securities of the Company or any other party, nor does it constitute a solicitation of any proxy or vote.
Contacts
Investor Relations:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
[email protected]
Media:
Carissa Felger / Sam Cohen
Gasthalter & Co.
(212) 257-4170
[email protected]
SOURCE: KindlyMD, Inc.
View the original press release on ACCESS Newswire
G.Stevens--AMWN